Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Salbutamol Sulfate Inhalation Powder

Approval Number

国药准字HJ20130596

CompanyORION CORPORATION

Registration Date

December 11, 2023

Previous Approval Numbers

H20130596

Drug Information

Generic Name

硫酸沙丁胺醇吸入粉雾剂

Dosage Form

吸入粉雾剂

Strength

200μg/吸（按C₁₃H₂₁NO₃计），200吸/支

Drug Type

化学药品

Registration Date

December 11, 2023

Expiry Date

December 10, 2028

Company Information

Applicant Company

Company NameORION CORPORATION

Company Address

Orionintie 1, 02200 Espoo, Finland

Manufacturing Company

Company NameORION CORPORATION

Company Address

Orionintie 1, P.O.Box 65, Espoo,02200, Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

硫酸沙丁胺醇吸入粉雾剂 - NMPA 批准文号 | MedPath